
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.190 | 29.130 | 28.940 |
Shares | 100.630 | 100.630 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 12.368 | 11.640 |
Price to Book | 1.913 | 1.445 |
Price to Sales | 1.015 | 0.944 |
Price to Cash Flow | 6.599 | 6.055 |
Dividend Yield | 4.849 | 4.302 |
5 Years Earnings Growth | 8.117 | 9.323 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 20.070 | 13.349 |
Consumer Defensive | 16.020 | 10.162 |
Financial Services | 14.700 | 22.020 |
Industrials | 12.310 | 15.356 |
Communication Services | 9.580 | 6.310 |
Technology | 8.100 | 5.706 |
Basic Materials | 4.870 | 6.486 |
Consumer Cyclical | 4.810 | 8.380 |
Utilities | 4.010 | 4.364 |
Energy | 3.730 | 7.336 |
Real Estate | 1.810 | 2.015 |
Number of long holdings: 88
Number of short holdings: 12
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Roche Holding Participation | CH0012032048 | 3.85 | 268.20 | +0.19% | |
Novartis | CH0012005267 | 3.54 | 97.08 | +0.42% | |
Nestle | CH0038863350 | 3.43 | 86.70 | -0.49% | |
Novo Nordisk A/S Class B | DK0060534915 | 3.43 | - | - | |
Sanofi | FR0000120578 | 2.67 | 88.41 | +1.05% | |
GSK PLC | GB0009252882 | 2.44 | - | - | |
Rio Tinto PLC | GB0007188757 | 2.24 | 4,355.5 | -0.81% | |
SAP | DE0007164600 | 2.14 | 272.350 | +0.52% | |
BAE Systems | GB0002634946 | 1.84 | 1,930.50 | -2.60% | |
Allianz | DE0008404005 | 1.80 | 355.30 | +0.40% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
US Large Cap Growth Fund Class A EU | 1.91B | 33.75 | 10.07 | 15.37 | ||
US Large Cap Growth Fund Class GA E | 1.91B | 33.96 | 10.28 | 15.61 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review